Your browser doesn't support javascript.
loading
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.
Qian, Jun; Hassanein, Mohamed; Hoeksema, Megan D; Harris, Bradford K; Zou, Yong; Chen, Heidi; Lu, Pengcheng; Eisenberg, Rosana; Wang, Jing; Espinosa, Allan; Ji, Xiangming; Harris, Fredrick T; Rahman, S M Jamshedur; Massion, Pierre P.
Afiliação
  • Qian J; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Hassanein M; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Hoeksema MD; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Harris BK; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Zou Y; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Chen H; Department of Biostatistics, Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Lu P; Department of Biostatistics, Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Eisenberg R; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232;
  • Wang J; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37203;
  • Espinosa A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Ji X; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Harris FT; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232; Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208; and.
  • Rahman SM; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Massion PP; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Thoracic Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232; Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212 pierre.massion@vanderbilt.edu
Proc Natl Acad Sci U S A ; 112(11): 3469-74, 2015 Mar 17.
Article em En | MEDLINE | ID: mdl-25733852
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 3 / Proteínas de Ligação a RNA / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 3 / Proteínas de Ligação a RNA / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article